Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Infection
100%
Infectious Disease
100%
COVID-19
43%
Severe Acute Respiratory Syndrome Coronavirus 2
32%
Escherichia coli
30%
Streptococcus pneumonia
26%
Staphylococcus aureus
26%
Prevalence
22%
Klebsiella pneumoniae
22%
Methicillin-Resistant Staphylococcus Aureus
18%
Omicron Coronavirus Variant
18%
Serotype
17%
Minimum Inhibitory Concentration
17%
Susceptibility
16%
Antibiotic Resistance
15%
Mortality Rate
15%
In Vitro
15%
Infectious Agent
14%
Colistin
13%
Multilocus Sequence Typing
13%
Breakthrough Infection
13%
Pseudomonas aeruginosa
12%
Enterococcus faecium
11%
Antimicrobial Agent
10%
Urinary Tract
9%
Vancomycin-Resistant Enterococcus
9%
Neutralizing Antibody
9%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
9%
Plaque Reduction Neutralization Test
9%
Wild Type
9%
Titer
9%
Cohort Effect
9%
Gram-Negative Bacteria
8%
Acinetobacter
8%
Plasmid
8%
Acinetobacter Baumannii
8%
Abscess
7%
Cytomegalovirus
7%
Penicillin
7%
Pneumococcus
7%
Epidemiology
7%
Molecular Epidemiology
7%
Biofilm
6%
Antibiotic Sensitivity
6%
Immunogenicity
6%
Enterobacter
6%
Antibody Titer
6%
Spike Protein
6%
Multidrug Resistance
5%
Bacterium
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bloodstream Infection
74%
Infection
40%
Penicillinase
26%
Diseases
25%
Staphylococcus aureus
24%
Pneumonia
20%
Escherichia coli
19%
Infectious Agent
17%
Vancomycin
17%
Cohort Study
16%
Extended Spectrum Beta Lactamase
16%
Pseudomonas aeruginosa
15%
Coronavirinae
14%
Antimicrobial Therapy
14%
Klebsiella pneumoniae
14%
Antibiotics
14%
Antiinfective Agent
13%
Clinical Feature
12%
Malignant Neoplasm
12%
Methicillin-Resistant Staphylococcus Aureus
12%
Antimicrobial Agent
12%
Mortality Rate
11%
Acute Pyelonephritis
11%
Meticillin
11%
Streptococcus pneumonia
10%
Prevalence
10%
Imipenem
9%
Ciprofloxacin
9%
Adverse Event
9%
Staphylococcal Bacteremia
8%
Rifampicin
8%
Epidemiology
8%
Antibiotic Resistance
8%
Carbapenem
7%
Acinetobacter
7%
Ceftriaxone
7%
Quinolone Derivative
7%
Carbapenem Derivative
7%
Vaccination
7%
Extended Spectrum Beta Lactamase Producing Escherichia Coli
7%
Gram Negative Sepsis
6%
Antibiotic Therapy
6%
Staphylococcal Infection
6%
Acinetobacter Baumannii
6%
Hematologic Malignancy
6%
Tuberculosis
5%
Tigecycline
5%
Meropenem
5%
Pneumococcal Meningitis
5%
Levofloxacin
5%
Medicine and Dentistry
COVID-19
40%
Infection
34%
Bloodstream Infection
31%
Pneumonia
22%
Middle East Respiratory Syndrome
14%
Streptococcus pneumonia
14%
Pneumococcal Pneumonia
14%
Escherichia coli
13%
Methicillin Resistant Staphylococcus Aureus
13%
Health Care Personnel
12%
Cohort Analysis
12%
Severe Acute Respiratory Syndrome Coronavirus 2
11%
Diseases
11%
Penicillinase
10%
Odds Ratio
10%
Cohort Effect
10%
Pathogen
9%
Mortality Rate
9%
Retrospective Cohort Study
9%
Staphylococcus aureus
9%
Extended Spectrum Beta Lactamase
8%
Clinical Significance
8%
Antimicrobial Therapy
8%
Cytomegalovirus
8%
Klebsiella pneumoniae
8%
Tertiary Care
8%
Tuberculosis
8%
Surgical Infection
7%
Middle East Respiratory Syndrome Coronavirus
7%
Sepsis
6%
Clinical Feature
6%
Oral
6%
Gram-Negative Bacteria
6%
Antibiotic Resistance
6%
Invasive Aspergillosis
6%
Kidney Graft
5%
Serotype
5%
Liver Graft
5%
Vancomycin Resistant Enterococcus
5%
Infectious Disease
5%
Multivariate Analysis
5%
Cytomegalovirus Infection
5%
Septic Shock
5%
Gram Negative Sepsis
5%
Catheter Infection
5%
Mycosis
5%